Spineart completes enrollment for cervical disc trial

Spineart completed enrollment for the U.S. investigational device exemption trial with the Baguera C cervical disc implant, the devicemaker said Feb. 29.

Advertisement

The trial will compare Baguera C in single-level cervical disc replacement to the Mobi-C , according to a news release. The trial will include about 300 patients across 30 study sites.

The Baguera C disc is designed to move in all six degrees of freedom and maintain the natural behavior of the spine. More than 60,000 implants have been sold globally since 2008.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.